227 related articles for article (PubMed ID: 38616849)
1. Impact of metabolic dysfunction-associated steatotic liver disease on COVID-19 hospitalizations: A propensity-matched analysis of the United States.
Sohail A; Ali H; Patel P; Subramanium S; Dahiya DS; Sohail AH; Gangwani MK; Satapathy SK
World J Virol; 2024 Mar; 13(1):91149. PubMed ID: 38616849
[TBL] [Abstract][Full Text] [Related]
2. Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United States.
Inayat F; Ali H; Patel P; Dhillon R; Afzal A; Rehman AU; Afzal MS; Zulfiqar L; Nawaz G; Goraya MHN; Subramanium S; Agrawal S; Satapathy SK
World J Virol; 2023 Sep; 12(4):221-232. PubMed ID: 37970569
[TBL] [Abstract][Full Text] [Related]
3. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
[TBL] [Abstract][Full Text] [Related]
4. Impact of HIV Infection on Liver and Cardiovascular Outcomes in Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Wong RJ; Yang Z; Yeoh A; Do A; Ahmed A; Cheung R
Am J Gastroenterol; 2024 Apr; ():. PubMed ID: 38477465
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Metabolic Bariatric Surgery on Cardiovascular Diseases in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
Esparham A; Shoar S; Mehri A; Khorgami Z; Modukuru VR
Obes Surg; 2024 Apr; ():. PubMed ID: 38662250
[TBL] [Abstract][Full Text] [Related]
6. Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.
Gao J; Li Y; Zhang Y; Zhan X; Tian X; Li J; Wang R; He Y; Wang A; Wu S
J Am Heart Assoc; 2024 Mar; 13(5):e032604. PubMed ID: 38390843
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.
Naseem K; Sohail A; Quang Nguyen V; Khan A; Cooper G; Lashner B; Katz J; Cominelli F; Regueiro M; Mansoor E
Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37725039
[TBL] [Abstract][Full Text] [Related]
8. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.
Zahoor F; Saeed NU; Javed S; Sadiq HZ; Mand Khan F; Haider M; Shafqat MN; Maqbool A; Chaudhry A
Cureus; 2023 Oct; 15(10):e47240. PubMed ID: 38021965
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohort.
Ossima AN; Brzustowski A; Paradis V; Van Beers B; Postic C; Laouénan C; Pol S; Castéra L; Gautier JF; Czernichow S; Vallet-Pichard A; Larger E; Serfaty L; Zins M; Valla D; Zaleski ID
Clin Diabetes Endocrinol; 2024 Apr; 10(1):9. PubMed ID: 38659082
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular complications during delivery hospitalizations in patients with nonalcoholic fatty liver disease in pregnancy.
Niu C; Zhang J; Khalid N; Zhu K; Syed T; Liu H; Okolo PI
Eur J Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38874917
[TBL] [Abstract][Full Text] [Related]
11. Predictors of inpatient outcomes of COVID-19 infection in patients with cirrhosis in the early pandemic phase: A nationwide survey.
Sohail A; Naseem K; Khan A; Adhami T; Brown K
JGH Open; 2023 Dec; 7(12):889-898. PubMed ID: 38162845
[TBL] [Abstract][Full Text] [Related]
12. Adverse pregnancy outcomes as a risk factor for new-onset metabolic dysfunction-associated steatotic liver disease in postpartum women: A nationwide study.
Jung YM; Lee SM; Wi W; Oh MJ; Park JS; Cho GJ; Kim W
JHEP Rep; 2024 Apr; 6(4):101033. PubMed ID: 38524668
[TBL] [Abstract][Full Text] [Related]
13. Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition Examination Survey 2001 to 2018.
Tan Z; Wu Y; Meng Y; Liu C; Deng B; Zhen J; Dong W
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068789
[TBL] [Abstract][Full Text] [Related]
14. Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.
Wu T; Ye J; Mo S; Ye M; Li X; Li Q; Wang W; Zheng Q; Luo K; Zhang Y; Tu S; Che D; Gong R; Chen X; Miu R; Shao C; Sun Y; Zhong B
J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38695344
[TBL] [Abstract][Full Text] [Related]
15. Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.
Son DH; Kwon YJ; Lee JH
J Nutr Health Aging; 2024 Jun; 28(6):100270. PubMed ID: 38833877
[TBL] [Abstract][Full Text] [Related]
16. Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults.
Song R; Li Z; Zhang Y; Tan J; Chen Z
Liver Int; 2024 Apr; 44(4):1051-1060. PubMed ID: 38293788
[TBL] [Abstract][Full Text] [Related]
17. Steatotic liver disease, MASLD and risk of chronic kidney disease.
Bilson J; Mantovani A; Byrne CD; Targher G
Diabetes Metab; 2024 Jan; 50(1):101506. PubMed ID: 38141808
[TBL] [Abstract][Full Text] [Related]
18. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.
Haider MB; Al Sbihi A; Chaudhary AJ; Haider SM; Edhi AI
World J Hepatol; 2022 Sep; 14(9):1804-1816. PubMed ID: 36185720
[TBL] [Abstract][Full Text] [Related]
19. Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study.
Simon TG; Ebrahimi F; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Cardiovasc Diabetol; 2023 Dec; 22(1):343. PubMed ID: 38093277
[TBL] [Abstract][Full Text] [Related]
20. Exploring the landscape of steatotic liver disease in the general US population.
Ciardullo S; Carbone M; Invernizzi P; Perseghin G
Liver Int; 2023 Nov; 43(11):2425-2433. PubMed ID: 37592856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
